Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples
Detection Principle
ImmunoAssay-Antibody
Target
IgG, IgA vs S1
Testing Method Category
ELISA
Testing Method
kits (Euroimmun)
Testing Method - Additional Info
SARS-CoV-2 IgG and IgA ELISAs, Euroimmun, Lübeck, Germany
Reported Performance
specificity: 91.9% (IgG), 73.0% (IgA)
Sample Size
37 samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements